Estera Okoń

634 total citations
22 papers, 455 citations indexed

About

Estera Okoń is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Estera Okoń has authored 22 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Pharmacology and 6 papers in Oncology. Recurrent topics in Estera Okoń's work include Histone Deacetylase Inhibitors Research (7 papers), Epigenetics and DNA Methylation (5 papers) and Berberine and alkaloids research (3 papers). Estera Okoń is often cited by papers focused on Histone Deacetylase Inhibitors Research (7 papers), Epigenetics and DNA Methylation (5 papers) and Berberine and alkaloids research (3 papers). Estera Okoń collaborates with scholars based in Poland, Finland and Greece. Estera Okoń's co-authors include Anna Wawruszak, Andrzej Stepulak, Marta Hałasa, Wirginia Kukuła‐Koch, Adolfo Rivero‐Müller, Lidia Borkiewicz, Jarogniew J. Łuszczki, Małgorzata Guz, Karolina Okła and Joanna Kałafut and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Cells.

In The Last Decade

Estera Okoń

20 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Estera Okoń Poland 9 314 96 87 38 36 22 455
Marta Hałasa Poland 11 330 1.1× 107 1.1× 46 0.5× 29 0.8× 41 1.1× 22 453
Robert Kleszcz Poland 15 356 1.1× 94 1.0× 119 1.4× 39 1.0× 67 1.9× 39 590
Xiaoyan Shi China 16 333 1.1× 83 0.9× 156 1.8× 23 0.6× 33 0.9× 34 587
Xiang-Lin Tan United States 11 267 0.9× 165 1.7× 117 1.3× 21 0.6× 34 0.9× 13 440
Seema Noor Germany 11 302 1.0× 62 0.6× 54 0.6× 65 1.7× 49 1.4× 13 518
Shreya Kar Singapore 6 290 0.9× 138 1.4× 101 1.2× 16 0.4× 43 1.2× 8 500
Andrew DeCastro United States 11 249 0.8× 156 1.6× 97 1.1× 53 1.4× 43 1.2× 15 472
Nikhil Vad United States 10 246 0.8× 72 0.8× 56 0.6× 19 0.5× 50 1.4× 14 420
Mayrel Palestino Domínguez Mexico 9 201 0.6× 99 1.0× 81 0.9× 21 0.6× 26 0.7× 13 439

Countries citing papers authored by Estera Okoń

Since Specialization
Citations

This map shows the geographic impact of Estera Okoń's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Estera Okoń with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Estera Okoń more than expected).

Fields of papers citing papers by Estera Okoń

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Estera Okoń. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Estera Okoń. The network helps show where Estera Okoń may publish in the future.

Co-authorship network of co-authors of Estera Okoń

This figure shows the co-authorship network connecting the top 25 collaborators of Estera Okoń. A scholar is included among the top collaborators of Estera Okoń based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Estera Okoń. Estera Okoń is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okoń, Estera, et al.. (2025). Chemopreventive and Anticancer Activity of Selected Triterpenoids in Melanoma. Cancers. 17(10). 1625–1625.
2.
Kukuła‐Koch, Wirginia, Estera Okoń, Anna Wawruszak, et al.. (2024). Vaccinium Species—Unexplored Sources of Active Constituents for Cosmeceuticals. Biomolecules. 14(9). 1110–1110. 5 indexed citations
3.
Okoń, Estera, et al.. (2024). The Activity of 1,8-Dihydroanthraquinone Derivatives in Nervous System Cancers. Molecules. 29(24). 5989–5989.
4.
Okoń, Estera, et al.. (2023). Therapeutic Potential of 1,8-Dihydroanthraquinone Derivatives for Breast Cancer. International Journal of Molecular Sciences. 24(21). 15789–15789. 4 indexed citations
5.
Okoń, Estera, Anna Wawruszak, Adrianna Sławińska-Brych, et al.. (2023). Emodin-8-O-Glucoside—Isolation and the Screening of the Anticancer Potential against the Nervous System Tumors. Molecules. 28(21). 7366–7366. 4 indexed citations
6.
7.
Wawruszak, Anna, Jarogniew J. Łuszczki, Estera Okoń, Arkadiusz Czerwonka, & Andrzej Stepulak. (2022). Antagonistic Pharmacological Interaction between Sirtuin Inhibitor Cambinol and Paclitaxel in Triple-Negative Breast Cancer Cell Lines: An Isobolographic Analysis. International Journal of Molecular Sciences. 23(12). 6458–6458. 7 indexed citations
8.
Wawruszak, Anna, Jarogniew J. Łuszczki, Arkadiusz Czerwonka, Estera Okoń, & Andrzej Stepulak. (2022). Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells. Cells. 11(7). 1211–1211. 18 indexed citations
9.
10.
Wawruszak, Anna, Jarogniew J. Łuszczki, Marta Hałasa, et al.. (2021). Sensitization of MCF7 Cells with High Notch1 Activity by Cisplatin and Histone Deacetylase Inhibitors Applied Together. International Journal of Molecular Sciences. 22(10). 5184–5184. 7 indexed citations
11.
Hałasa, Marta, Jarogniew J. Łuszczki, Magdalena Dmoszyńska‐Graniczka, et al.. (2021). Antagonistic Interaction between Histone Deacetylase Inhibitor: Cambinol and Cisplatin—An Isobolographic Analysis in Breast Cancer In Vitro Models. International Journal of Molecular Sciences. 22(16). 8573–8573. 7 indexed citations
12.
Wawruszak, Anna, et al.. (2021). Vorinostat (SAHA) and Breast Cancer: An Overview. Cancers. 13(18). 4700–4700. 79 indexed citations
13.
Wawruszak, Anna, Marta Hałasa, Estera Okoń, Wirginia Kukuła‐Koch, & Andrzej Stepulak. (2021). Valproic Acid and Breast Cancer: State of the Art in 2021. Cancers. 13(14). 3409–3409. 49 indexed citations
14.
Okoń, Estera, Jarogniew J. Łuszczki, Wirginia Kukuła‐Koch, et al.. (2020). Synergistic or Additive Pharmacological Interactions between Magnoflorine and Cisplatin in Human Cancer Cells of Different Histological Origin. International Journal of Molecular Sciences. 21(8). 2848–2848. 18 indexed citations
15.
Okoń, Estera, Wirginia Kukuła‐Koch, Marta Hałasa, et al.. (2020). Magnoflorine—Isolation and the Anticancer Potential against NCI-H1299 Lung, MDA-MB-468 Breast, T98G Glioma, and TE671 Rhabdomyosarcoma Cancer Cells. Biomolecules. 10(11). 1532–1532. 30 indexed citations
16.
Okoń, Estera, et al.. (2020). Advances in Chemistry and Bioactivity of Magnoflorine and Magnoflorine-Containing Extracts. International Journal of Molecular Sciences. 21(4). 1330–1330. 47 indexed citations
17.
Wawruszak, Anna, Estera Okoń, Witold Jeleniewicz, et al.. (2019). <p>Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties</p>. Cancer Management and Research. Volume 11. 8345–8358. 17 indexed citations
18.
Guz, Małgorzata, Estera Okoń, Witold Jeleniewicz, et al.. (2019). MMP-9 and MMP-2 regulation in patients undergoing non-oncological and non-vascular elective surgery independent of the use of propofol or sevoflurane. Pharmacological Reports. 71(3). 528–534. 2 indexed citations
19.
Wawruszak, Anna, Joanna Kałafut, Estera Okoń, et al.. (2019). Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells. Cancers. 11(2). 148–148. 85 indexed citations
20.
Guz, Małgorzata, Adolfo Rivero‐Müller, Estera Okoń, et al.. (2014). MicroRNAs-Role in Lung Cancer. Disease Markers. 2014. 1–13. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Hałasa Breakdown of academic impact, for papers by Robert Kleszcz Breakdown of academic impact, for papers by Xiaoyan Shi Breakdown of academic impact, for papers by Xiang-Lin Tan Breakdown of academic impact, for papers by Seema Noor Breakdown of academic impact, for papers by Shreya Kar Breakdown of academic impact, for papers by Andrew DeCastro Breakdown of academic impact, for papers by Nikhil Vad Breakdown of academic impact, for papers by Mayrel Palestino Domínguez
Rankless by CCL
2026